Target intelligence / Profile preview

Chicken infectious anemia virus (CIAV)

Target
CIAV
Molecular classification
Virus, Gyrovirus, Anelloviridae
01

Overview

Chicken infectious anemia virus (CIAV) is a small, non-enveloped, single-stranded circular DNA virus belonging to the genus Gyrovirus within the family Anelloviridae (ICTV, 2023). It is the primary causative agent of chicken infectious anemia, a condition characterized by severe aplastic anemia and systemic lymphoid atrophy in young chicks, leading to significant immunosuppression (MSD Veterinary Manual). The viral genome encodes three proteins: VP1 (capsid), VP2 (scaffold/phosphatase), and VP3, also known as Apoptin (UniProt). Apoptin is of particular interest in biotechnology because it induces p53-independent apoptosis specifically in transformed or malignant cells while sparing normal cells (PubMed, PMID: 16418673). In veterinary medicine, the virus is targeted primarily through live attenuated or inactivated vaccines administered to breeder flocks to provide passive immunity to offspring (ScienceDirect). While no specific small-molecule antivirals are currently used, the virus remains a major focus for poultry health management and a model for studying selective apoptosis in oncology.

Other names
Chicken anemia virusCAVBlue wing disease virusAnemia dermatitis syndrome virus
02

Mechanism of action

Vaccines against Chicken infectious anemia virus function by eliciting neutralizing antibodies, primarily directed at the VP1 capsid protein, which prevent viral attachment and entry into host hemocytoblasts and T-cell precursors. In experimental contexts, the viral protein Apoptin (VP3) acts as a therapeutic agent by translocating to the nucleus of tumor cells and inducing p53-independent apoptosis through the activation of caspase cascades (PubMed, PMID: 16418673).

03

Biological functions

Viral replicationApoptosis inductionImmunosuppressionHost cell cycle modulation
04

Disease associations

InfectionImmunosuppressionAplastic anemia
05

Safety considerations

Reversion to virulence of live vaccine strainsVertical transmission to progenyEnhanced susceptibility to secondary pathogens
06

Interacting drugs

Live attenuated CIAV vaccine

1 more in the full profile.

07

Biomarkers

Hematocrit levelViral DNA loadAnti-VP1 antibodies

Beyond the preview

Go deeper on Chicken infectious anemia virus (CIAV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chicken infectious anemia virus (CIAV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call